Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Jul;126(1):e208-14.
doi: 10.1542/peds.2010-0008. Epub 2010 Jun 21.

N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia

Nicholas Ah Mew  1 , Robert McCarter, Yevgeny Daikhin, Itzhak Nissim, Marc Yudkoff, Mendel Tuchman
Affiliations
Clinical Trial

N-carbamylglutamate augments ureagenesis and reduces ammonia and glutamine in propionic acidemia

Nicholas Ah Mew et al. Pediatrics. 2010 Jul.

Abstract

Objectives: The objective of this study was to determine whether N-carbamylglutamate (NCG) reduces plasma levels of ammonia and glutamine and increases the rate of ureagenesis in patients with propionic acidemia (PA).

Methods: Identical 4-hour studies were performed before and immediately after a 3-day trial of oral NCG in 7 patients with PA. An oral bolus of [(13)C]sodium acetate was administered at the start of each study, and sequential blood samples were obtained to measure [(13)C]urea, ammonia, urea, and amino acids.

Results: With longitudinal mixed-effects linear regression, peak [(13)C]urea increased after treatment with NCG (from 2.2 to 3.8 microM; P < .0005). There were concomitant decreases in mean plasma ammonia (59-43 microM; P < .018) and glutamine (552-331 microM; P < .0005).

Conclusions: NCG augments ureagenesis and decreases plasma ammonia and glutamine in patients with PA. The drug may serve as an important therapeutic adjunct in the treatment of acute hyperammonemia in this disorder.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall trial timeline. Identical studies were performed before (‘day 1’) and immediately following (‘day 4’) a 3-day course of N-carbamylglutamate at a dose of 100 mg/kg/d or 2.2g/m2/d if ≥25 kg. Plasma samples for ammonia, urea, amino acids and [13C]urea were obtained at T0, 15, 30, 45, 60, 90, 120, 180, and 240 min.
Figure 2
Figure 2
Isotopic enrichment in plasma 13CO2 (A), and [13C]urea (B) in 7 subjects with propionic acidemia who were administered 27.5 mg/kg of [1-13C]sodium-acetate. Results are model estimates +/- 95% CI. Subject 4 contributes to mean data only at time-points 0, 15, 30, 60 and 120 minutes.
Figure 2
Figure 2
Isotopic enrichment in plasma 13CO2 (A), and [13C]urea (B) in 7 subjects with propionic acidemia who were administered 27.5 mg/kg of [1-13C]sodium-acetate. Results are model estimates +/- 95% CI. Subject 4 contributes to mean data only at time-points 0, 15, 30, 60 and 120 minutes.
Figure 3
Figure 3
Plasma levels of ammonia (A), glutamine (B), alanine (C), glycine (D) and urea (E) in 7 patients with propionic acidemia before and following a 3-day treatment with N-carbamylglutamate. Mean values +/- 95% CI are shown in bold. 1Based on log transformation; 2Based on square root transformation
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tuchman M, Lee B, Lichter-Konecki U, Summar ML, Yudkoff M, Cederbaum SD, et al. Cross-sectional multicenter study of patients with urea cycle disorders in the United States. Mol Genet Metab. 2008;94(4):397–402. - PMC - PubMed
    1. Brusilow SW, Maestri NE. Urea cycle disorders: diagnosis, pathophysiology, and therapy. Adv Pediatr. 1996;43:127–70. - PubMed
    1. Batshaw ML, Brusilow S, Waber L, Blom W, Brubakk AM, Burton BK, et al. Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion. N Engl J Med. 1982;306(23):1387–92. - PubMed
    1. Batshaw ML, Brusilow SW. Treatment of hyperammonemic coma caused by inborn errors of urea synthesis. J Pediatr. 1980;97(6):893–900. - PubMed
    1. Hall LM, Metzenberg RL, Cohen PP. Isolation and characterization of a naturally occurring cofactor of carbamyl phosphate biosynthesis. J Biol Chem. 1958;230(2):1013–21. - PubMed

Publication types

MeSH terms